# Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail

> **NCT01180647** · PHASE3 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 48 (actual)

## Conditions studied

- Opiate Dependence

## Interventions

- **DRUG:** Extended-Release Naltrexone
- **BEHAVIORAL:** Motivational Enhancement Counseling

## Key facts

- **NCT ID:** NCT01180647
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2016-04-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01180647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01180647, "Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01180647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*